Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
+0.0010 (5.88%)
Sep 17, 2026, 3:55 PM AEST
Atomo Diagnostics Company Description
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide.
The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand.
It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Atomo Diagnostics Limited
| Country | Australia |
| Founded | 2010 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Cheri Walker |
Contact Details
Address: 3-5 George Street Leichhardt, NSW 2040 Australia | |
| Phone | 61 2 9099 4750 |
| Website | atomodiagnostics.com |
Stock Details
| Ticker Symbol | AT1 |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000080327 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Cheri L. Walker Ph.D. | Interim Chief Executive Officer and Director |
| Chandra Sukumar | Chief Operating Officer |
| Mathew Leslie Watkins C.A. | Company Secretary |